Acebutolol
Phentolamine may increase the hypotensive activities of Acebutolol.
Acemetacin
The therapeutic efficacy of Phentolamine can be decreased when used in combination with Acemetacin.
Aldesleukin
The risk or severity of adverse effects can be increased when Phentolamine is combined with Aldesleukin.
Advertisement
Alfuzosin
Alfuzosin may increase the hypotensive activities of Phentolamine.
Aliskiren
Phentolamine may increase the hypotensive activities of Aliskiren.
Alprenolol
Phentolamine may increase the hypotensive activities of Alprenolol.
Advertisement
Ambrisentan
Phentolamine may increase the hypotensive activities of Ambrisentan.
Amifostine
Phentolamine may increase the hypotensive activities of Amifostine.
Amifostine Anhydrous
Phentolamine may increase the hypotensive activities of Amifostine.
Advertisement
Amiloride
The risk or severity of adverse effects can be increased when Phentolamine is combined with Amiloride.
Amiodarone
The risk or severity of adverse effects can be increased when Amiodarone is combined with Phentolamine.
Amlodipine
Amlodipine may increase the hypotensive activities of Phentolamine.
Amobarbital
Amobarbital may increase the hypotensive activities of Phentolamine.
Amphetamine
Amphetamine may increase the hypotensive activities of Phentolamine.
Amphotericin B
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Phentolamine.
amphotericin B liposomal
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Phentolamine.
Amyl Nitrite
The risk or severity of adverse effects can be increased when Phentolamine is combined with Amyl Nitrite.
Apomorphine
The risk or severity of adverse effects can be increased when Apomorphine is combined with Phentolamine.
Apraclonidine
The risk or severity of adverse effects can be increased when Phentolamine is combined with Apraclonidine.
Aripiprazole
Aripiprazole may increase the hypotensive activities of Phentolamine.
Arsenic Trioxide
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Phentolamine.
Atenolol
Atenolol may increase the hypotensive activities of Phentolamine.
Avanafil
Avanafil may increase the antihypertensive activities of Phentolamine.
Azilsartan
The risk or severity of adverse effects can be increased when Phentolamine is combined with Azilsartan medoxomil.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Phentolamine is combined with Azilsartan medoxomil.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Phentolamine is combined with Azilsartan medoxomil.
Barbexaclone
Barbexaclone may increase the hypotensive activities of Phentolamine.
Barbital
Barbital may increase the hypotensive activities of Phentolamine.
Benazepril
Benazepril may increase the hypotensive activities of Phentolamine.
Bendroflumethiazide
Bendroflumethiazide may increase the hypotensive activities of Phentolamine.
Bepridil
Phentolamine may increase the hypotensive activities of Bepridil.
Betaxolol
Betaxolol may increase the hypotensive activities of Phentolamine.
Bethanidine
Bethanidine may increase the hypotensive activities of Phentolamine.
Bimatoprost
Phentolamine may increase the hypotensive activities of Bimatoprost.
Bisoprolol
Bisoprolol may increase the hypotensive activities of Phentolamine.
Bortezomib
The risk or severity of adverse effects can be increased when Bortezomib is combined with Phentolamine.
Bosentan
Bosentan may increase the hypotensive activities of Phentolamine.
Bretylium
Phentolamine may increase the hypotensive activities of Bretylium.
Brimonidine
Brimonidine may increase the antihypertensive activities of Phentolamine.
Bromocriptine
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Phentolamine.
Bumetanide
The risk or severity of adverse effects can be increased when Phentolamine is combined with Bumetanide.
Bupivacaine
The risk or severity of adverse effects can be increased when Bupivacaine is combined with Phentolamine.
Bupranolol
Phentolamine may increase the hypotensive activities of Bupranolol.
Cafedrine
Phentolamine may increase the hypotensive activities of Cafedrine.
Canagliflozin
The risk or severity of adverse effects can be increased when Phentolamine is combined with Canagliflozin.
Canagliflozin Anhydrous
The risk or severity of adverse effects can be increased when Phentolamine is combined with Canagliflozin.
Candesartan
Phentolamine may increase the hypotensive activities of Candesartan.
Candesartan Cilexetil
Phentolamine may increase the hypotensive activities of Candesartan cilexetil.
Captopril
Phentolamine may increase the hypotensive activities of Captopril.
Carteolol
Carteolol may increase the hypotensive activities of Phentolamine.
Carvedilol
Phentolamine may increase the hypotensive activities of Carvedilol.
Celiprolol
Phentolamine may increase the hypotensive activities of Celiprolol.
Chlorothiazide
Phentolamine may increase the hypotensive activities of Chlorothiazide.
Chlorpromazine
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Phentolamine.
Chlorthalidone
Chlorthalidone may increase the hypotensive activities of Phentolamine.
Cicletanine
Phentolamine may increase the hypotensive activities of Cicletanine.
Cilazapril
Phentolamine may increase the hypotensive activities of Cilazapril.
Clevidipine
The risk or severity of adverse effects can be increased when Phentolamine is combined with Clevidipine.
Clevidipine butyrate
The risk or severity of adverse effects can be increased when Phentolamine is combined with Clevidipine.
Clofarabine
The risk or severity of adverse effects can be increased when Clofarabine is combined with Phentolamine.
Clomipramine
The risk or severity of adverse effects can be increased when Clomipramine is combined with Phentolamine.
Clonidine
Clonidine may increase the hypotensive activities of Phentolamine.
Clozapine
The risk or severity of adverse effects can be increased when Clozapine is combined with Phentolamine.
Conivaptan
The risk or severity of adverse effects can be increased when Conivaptan is combined with Phentolamine.
Cryptenamine
Phentolamine may increase the hypotensive activities of Cryptenamine.
Cyclopenthiazide
Phentolamine may increase the hypotensive activities of Cyclopenthiazide.
Cyclothiazide
Cyclothiazide may increase the hypotensive activities of Phentolamine.
Dapagliflozin
The risk or severity of adverse effects can be increased when Phentolamine is combined with Dapagliflozin.
Debrisoquin
Debrisoquin may increase the hypotensive activities of Phentolamine.
Deserpidine
Phentolamine may increase the hypotensive activities of Deserpidine.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Phentolamine.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Phentolamine is combined with Dexmedetomidine.
Diazoxide
Diazoxide may increase the hypotensive activities of Phentolamine.
Dichlorphenamide
The risk or severity of adverse effects can be increased when Phentolamine is combined with Diclofenamide.
Dihydralazine
Dihydralazine may increase the hypotensive activities of Phentolamine.
Diltiazem
Diltiazem may increase the hypotensive activities of Phentolamine.
Dinutuximab
The risk or severity of adverse effects can be increased when Phentolamine is combined with Dinutuximab.
Dipyridamole
The risk or severity of adverse effects can be increased when Phentolamine is combined with Dipyridamole.
Dorzolamide
Phentolamine may increase the hypotensive activities of Dorzolamide.
Doxazosin
Doxazosin may increase the hypotensive activities of Phentolamine.
Duloxetine
Phentolamine may increase the orthostatic hypotensive activities of Duloxetine.
Empagliflozin
The risk or severity of adverse effects can be increased when Phentolamine is combined with Empagliflozin.
Enalapril
Enalapril may increase the hypotensive activities of Phentolamine.
Enalaprilat
Phentolamine may increase the hypotensive activities of Enalaprilat.
Enalaprilat Anhydrous
Phentolamine may increase the hypotensive activities of Enalaprilat.
Eplerenone
The risk or severity of adverse effects can be increased when Phentolamine is combined with Eplerenone.
Epoprostenol
Phentolamine may increase the hypotensive activities of Epoprostenol.
Eprosartan
Phentolamine may increase the hypotensive activities of Eprosartan.
Esmolol
The risk or severity of adverse effects can be increased when Phentolamine is combined with Esmolol.
Ethacrynate
The risk or severity of adverse effects can be increased when Phentolamine is combined with Etacrynic acid.
Ethacrynic Acid
The risk or severity of adverse effects can be increased when Phentolamine is combined with Etacrynic acid.
Felodipine
Phentolamine may increase the hypotensive activities of Felodipine.
Fenoldopam
Phentolamine may increase the hypotensive activities of Fenoldopam.
Ferulic Acid
Phentolamine may increase the hypotensive activities of Ferulic acid.
Fosinopril
Fosinopril may increase the hypotensive activities of Phentolamine.
Furazolidone
Furazolidone may increase the hypotensive activities of Phentolamine.
Furosemide
The risk or severity of adverse effects can be increased when Phentolamine is combined with Furosemide.
Guanabenz
Guanabenz may increase the hypotensive activities of Phentolamine.
Guanadrel
Guanadrel may increase the hypotensive activities of Phentolamine.
Guanethidine
Phentolamine may increase the hypotensive activities of Guanethidine.
Guanfacine
Guanfacine may increase the hypotensive activities of Phentolamine.
Halothane
The risk or severity of adverse effects can be increased when Halothane is combined with Phentolamine.
Hexobarbital
Hexobarbital may increase the hypotensive activities of Phentolamine.
Hydralazine
Hydralazine may increase the hypotensive activities of Phentolamine.
Hydrochlorothiazide
Phentolamine may increase the hypotensive activities of Hydrochlorothiazide.
Hydroflumethiazide
Phentolamine may increase the hypotensive activities of Hydroflumethiazide.
Iloprost
The risk or severity of adverse effects can be increased when Iloprost is combined with Phentolamine.
Imidapril
The risk or severity of adverse effects can be increased when Imidapril is combined with Phentolamine.
Imipramine
The risk or severity of adverse effects can be increased when Imipramine is combined with Phentolamine.
Indapamide
Phentolamine may increase the hypotensive activities of Indapamide.
Indoramin
Indoramin may increase the hypotensive activities of Phentolamine.
Iproniazid
Iproniazid may increase the hypotensive activities of Phentolamine.
Irbesartan
Phentolamine may increase the hypotensive activities of Irbesartan.
Isocarboxazid
Isocarboxazid may increase the hypotensive activities of Phentolamine.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Phentolamine.
Isosorbide Dinitrate
The risk or severity of adverse effects can be increased when Phentolamine is combined with Isosorbide Dinitrate.
Isosorbide Mononitrate
The risk or severity of adverse effects can be increased when Phentolamine is combined with Isosorbide Mononitrate.
Isoxsuprine
The risk or severity of adverse effects can be increased when Phentolamine is combined with Isoxsuprine.
Isradipine
Isradipine may increase the hypotensive activities of Phentolamine.
Ketanserin
Ketanserin may increase the hypotensive activities of Phentolamine.
Labetalol
Labetalol may increase the hypotensive activities of Phentolamine.
Lacidipine
Phentolamine may increase the hypotensive activities of Lacidipine.
Latanoprost
Latanoprost may increase the hypotensive activities of Phentolamine.
Lercanidipine
Lercanidipine may increase the hypotensive activities of Phentolamine.
Levobunolol
The risk or severity of adverse effects can be increased when Phentolamine is combined with Levobunolol.
Levobupivacaine
The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Phentolamine.
Levodopa
Phentolamine may increase the orthostatic hypotensive activities of Levodopa.
Levosimendan
The risk or severity of adverse effects can be increased when Levosimendan is combined with Phentolamine.
Lisinopril
Phentolamine may increase the hypotensive activities of Lisinopril.
Lisinopril Anhydrous
Phentolamine may increase the hypotensive activities of Lisinopril.
Lofexidine
Phentolamine may increase the hypotensive activities of Lofexidine.
Losartan
Losartan may increase the hypotensive activities of Phentolamine.
Macitentan
Phentolamine may increase the hypotensive activities of Macitentan.
Manidipine
Phentolamine may increase the hypotensive activities of Manidipine.
Mannitol
The risk or severity of adverse effects can be increased when Phentolamine is combined with Mannitol.
Mecamylamine
Mecamylamine may increase the hypotensive activities of Phentolamine.
Mephobarbital
Methylphenobarbital may increase the hypotensive activities of Phentolamine.
Mepirodipine
Phentolamine may increase the antihypertensive activities of Barnidipine.
Methazolamide
The risk or severity of adverse effects can be increased when Phentolamine is combined with Methazolamide.
Methohexital
Methohexital may increase the hypotensive activities of Phentolamine.
Methyclothiazide
The risk or severity of adverse effects can be increased when Phentolamine is combined with Methyclothiazide.
Methyldopa
Phentolamine may increase the hypotensive activities of Methyldopa.
METHYLDOPA ANHYDROUS
Phentolamine may increase the hypotensive activities of Methyldopa.
Methylene blue
Methylene blue may increase the hypotensive activities of Phentolamine.
Methylphenidate
Methylphenidate may decrease the antihypertensive activities of Phentolamine.
Metipranolol
Phentolamine may increase the hypotensive activities of Metipranolol.
Metolazone
Metolazone may increase the hypotensive activities of Phentolamine.
Metoprolol
Metoprolol may increase the hypotensive activities of Phentolamine.
Metyrosine
Phentolamine may increase the hypotensive activities of Metyrosine.
Mibefradil
Phentolamine may increase the hypotensive activities of Mibefradil.
Minaprine
Minaprine may increase the hypotensive activities of Phentolamine.
Minoxidil
Minoxidil may increase the hypotensive activities of Phentolamine.
Moclobemide
Moclobemide may increase the hypotensive activities of Phentolamine.
Moexipril
Moexipril may increase the hypotensive activities of Phentolamine.
Molsidomine
Molsidomine may increase the hypotensive activities of Phentolamine.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Phentolamine.
Moxonidine
Moxonidine may increase the hypotensive activities of Phentolamine.
Nabilone
The risk or severity of adverse effects can be increased when Nabilone is combined with Phentolamine.
Nadolol
Phentolamine may increase the hypotensive activities of Nadolol.
Nebivolol
Phentolamine may increase the hypotensive activities of Nebivolol.
Nesiritide
The risk or severity of adverse effects can be increased when Phentolamine is combined with Nesiritide.
Nialamide
Nialamide may increase the hypotensive activities of Phentolamine.
Nicardipine
Nicardipine may increase the hypotensive activities of Phentolamine.
Nicorandil
Nicorandil may increase the hypotensive activities of Phentolamine.
Nifedipine
The risk or severity of adverse effects can be increased when Phentolamine is combined with Nifedipine.
Nilvadipine
Phentolamine may increase the hypotensive activities of Nilvadipine.
Nimodipine
Nimodipine may increase the hypotensive activities of Phentolamine.
Nisoldipine
Nisoldipine may increase the hypotensive activities of Phentolamine.
Nitrendipine
Phentolamine may increase the hypotensive activities of Nitrendipine.
Nitric Oxide
The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Phentolamine.
Nitroglycerin
The risk or severity of adverse effects can be increased when Phentolamine is combined with Nitroglycerin.
Nitroprusside
Nitroprusside may increase the hypotensive activities of Phentolamine.
Obinutuzumab
Phentolamine may increase the hypotensive activities of Obinutuzumab.
Olmesartan
Olmesartan may increase the hypotensive activities of Phentolamine.
Oxprenolol
Phentolamine may increase the hypotensive activities of Oxprenolol.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Phentolamine.
Papaverine
The risk or severity of adverse effects can be increased when Phentolamine is combined with Papaverine.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Phentolamine.
Pargyline
Pargyline may increase the hypotensive activities of Phentolamine.
Penbutolol
Phentolamine may increase the hypotensive activities of Penbutolol.
Pentobarbital
Pentobarbital may increase the hypotensive activities of Phentolamine.
Pentoxifylline
Pentoxifylline may increase the hypotensive activities of Phentolamine.
Perindopril
Phentolamine may increase the hypotensive activities of Perindopril.
Phenelzine
Phenelzine may increase the hypotensive activities of Phentolamine.
Phenobarbital
Phenobarbital may increase the hypotensive activities of Phentolamine.
Phenoxybenzamine
Phentolamine may increase the hypotensive activities of Phenoxybenzamine.
Pinacidil
Pinacidil may increase the hypotensive activities of Phentolamine.
Pindolol
Phentolamine may increase the hypotensive activities of Pindolol.
Pipamperone
The risk or severity of adverse effects can be increased when Phentolamine is combined with Pipamperone.
Polythiazide
Phentolamine may increase the hypotensive activities of Polythiazide.
Pramipexole
The risk or severity of adverse effects can be increased when Phentolamine is combined with Pramipexole.
Prazosin
Prazosin may increase the hypotensive activities of Phentolamine.
Primidone
Primidone may increase the hypotensive activities of Phentolamine.
Procarbazine
Procarbazine may increase the hypotensive activities of Phentolamine.
Propofol
The risk or severity of adverse effects can be increased when Phentolamine is combined with Propofol.
Propranolol
Propranolol may increase the hypotensive activities of Phentolamine.
Quetiapine
The risk or severity of adverse effects can be increased when Phentolamine is combined with Quetiapine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Phentolamine is combined with Quetiapine.
Quinapril
Phentolamine may increase the hypotensive activities of Quinapril.
Quinine
Quinine may increase the hypotensive activities of Phentolamine.
Ramipril
Ramipril may increase the hypotensive activities of Phentolamine.
Rasagiline
Rasagiline may increase the hypotensive activities of Phentolamine.
Remifentanil
The risk or severity of adverse effects can be increased when Phentolamine is combined with Remifentanil.
Rescinnamine
Phentolamine may increase the hypotensive activities of Rescinnamine.
Reserpine
Reserpine may increase the hypotensive activities of Phentolamine.
Rilmenidine
Rilmenidine may increase the hypotensive activities of Phentolamine.
Riociguat
Phentolamine may increase the hypotensive activities of Riociguat.
Risperidone
Phentolamine may increase the hypotensive activities of Risperidone.
Rituximab
Phentolamine may increase the hypotensive activities of Rituximab.
Ropinirole
The risk or severity of adverse effects can be increased when Phentolamine is combined with Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Phentolamine is combined with Ropivacaine.
Rotigotine
The risk or severity of adverse effects can be increased when Phentolamine is combined with Rotigotine.
Sacubitril
The risk or severity of adverse effects can be increased when Phentolamine is combined with Sacubitril.
Secobarbital
Secobarbital may increase the hypotensive activities of Phentolamine.
Selegiline
Selegiline may increase the hypotensive activities of Phentolamine.
Selexipag
Phentolamine may increase the hypotensive activities of Selexipag.
Sevoflurane
The risk or severity of adverse effects can be increased when Phentolamine is combined with Sevoflurane.
Sildenafil
Sildenafil may increase the antihypertensive activities of Phentolamine.
Sotalol
The risk or severity of adverse effects can be increased when Phentolamine is combined with Sotalol.
Spirapril
Phentolamine may increase the hypotensive activities of Spirapril.
Spironolactone
The risk or severity of adverse effects can be increased when Phentolamine is combined with Spironolactone.
Streptokinase
The risk or severity of adverse effects can be increased when Phentolamine is combined with Streptokinase.
Sufentanil
The risk or severity of adverse effects can be increased when Phentolamine is combined with Sufentanil.
Tadalafil
Tadalafil may increase the antihypertensive activities of Phentolamine.
Talinolol
Phentolamine may increase the hypotensive activities of Talinolol.
Tamsulosin
The risk or severity of adverse effects can be increased when Phentolamine is combined with Tamsulosin.
Telmisartan
Phentolamine may increase the hypotensive activities of Telmisartan.
Terazosin
The risk or severity of adverse effects can be increased when Phentolamine is combined with Terazosin.
Terlipressin
Phentolamine may increase the hypotensive activities of Terlipressin.
Thalidomide
The risk or severity of adverse effects can be increased when Phentolamine is combined with Thalidomide.
Theodrenaline
Phentolamine may increase the hypotensive activities of Theodrenaline.
Thiamylal
Thiamylal may increase the hypotensive activities of Phentolamine.
Thiopental
Thiopental may increase the hypotensive activities of Phentolamine.
Thiopental Sodium
Thiopental may increase the hypotensive activities of Phentolamine.
Thioridazine
The risk or severity of adverse effects can be increased when Phentolamine is combined with Thioridazine.
Tibolone
Phentolamine may increase the hypotensive activities of Tibolone.
Timolol
Timolol may increase the hypotensive activities of Phentolamine.
Timolol Anhydrous
Timolol may increase the hypotensive activities of Phentolamine.
Tizanidine
The risk or severity of adverse effects can be increased when Phentolamine is combined with Tizanidine.
Tolazoline
Phentolamine may increase the hypotensive activities of Tolazoline.
Tolcapone
The risk or severity of adverse effects can be increased when Phentolamine is combined with Tolcapone.
Toloxatone
Toloxatone may increase the hypotensive activities of Phentolamine.
Torsemide
Torasemide may increase the hypotensive activities of Phentolamine.
Trandolapril
Trandolapril may increase the hypotensive activities of Phentolamine.
Tranylcypromine
Tranylcypromine may increase the hypotensive activities of Phentolamine.
Travoprost
Travoprost may increase the hypotensive activities of Phentolamine.
Treprostinil
Treprostinil may increase the hypotensive activities of Phentolamine.
Tretinoin
The risk or severity of adverse effects can be increased when Phentolamine is combined with Tretinoin.
Triamterene
The risk or severity of adverse effects can be increased when Phentolamine is combined with Triamterene.
Trichlormethiazide
Phentolamine may increase the hypotensive activities of Trichlormethiazide.
Trimethaphan
Trimethaphan may increase the hypotensive activities of Phentolamine.
UNOPROSTONE
Phentolamine may increase the hypotensive activities of Unoprostone.
Urapidil
Urapidil may increase the hypotensive activities of Phentolamine.
Valsartan
Valsartan may increase the hypotensive activities of Phentolamine.
Vardenafil
Vardenafil may increase the antihypertensive activities of Phentolamine.
Verapamil
The risk or severity of adverse effects can be increased when Phentolamine is combined with Verapamil.
Vincamine
Phentolamine may increase the hypotensive activities of Vincamine.
Vinpocetine
Phentolamine may increase the hypotensive activities of Vinpocetine.
Xylometazoline
Phentolamine may increase the hypotensive activities of Xylometazoline.
Yohimbine
Yohimbine may decrease the antihypertensive activities of Phentolamine.
Zofenopril
Phentolamine may increase the hypotensive activities of Zofenopril.
